Clinical Trials Browser

Phase 1/2 × Anatomic Stage II Breast Cancer AJCC v8 × Fulvestrant × Clear all

NCT05319873 2025-05-13

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Phase 1/2 Recruiting

Anatomic Stage II Breast Cancer AJCC v8